Acute transverse myelitis in COVID-19 infection.
Acute Disease
Betacoronavirus
COVID-19
Coronavirus Infections
/ complications
Diagnosis, Differential
Glucocorticoids
/ therapeutic use
Humans
Magnetic Resonance Imaging
/ methods
Male
Methylprednisolone
/ therapeutic use
Middle Aged
Myelitis, Transverse
/ diagnostic imaging
Pandemics
Pneumonia, Viral
/ complications
SARS-CoV-2
Spine
/ diagnostic imaging
emergency medicine
infectious diseases
neurology
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
11 Aug 2020
11 Aug 2020
Historique:
entrez:
14
8
2020
pubmed:
14
8
2020
medline:
26
8
2020
Statut:
epublish
Résumé
A 60-year-old man presented to hospital with bilateral lower limb weakness, urinary retention and constipation. He had been diagnosed with COVID-19 10 days prior. Clinical examination revealed global weakness, increased tone, hyperreflexia and patchy paresthesia in his lower limbs bilaterally. Preliminary blood tests performed revealed a mildly elevated C reactive protein and erythrocyte sedimentation rate but was otherwise unremarkable. MRI scan of his whole spine demonstrated hyperintense T2 signal centrally from T7 to T10, suggestive of acute transverse myelitis. A lumbar puncture showed elevated protein count but normal glucose and white blood cell count. Serological testing for other viruses was negative. His neurological symptoms improved significantly after treatment with intravenous methylprednisone. This case highlights a potential neurological complication of COVID-19 infection.
Identifiants
pubmed: 32784242
pii: 13/8/e236720
doi: 10.1136/bcr-2020-236720
pmc: PMC7418849
pii:
doi:
Substances chimiques
Glucocorticoids
0
Methylprednisolone
X4W7ZR7023
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Neurol Sci. 2020 Jun 15;413:116832
pubmed: 32299017
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Int J Infect Dis. 2020 May;94:55-58
pubmed: 32251791
Brain Behav Immun. 2020 Jul;87:18-22
pubmed: 32240762
Lancet Respir Med. 2020 May;8(5):506-517
pubmed: 32272080
JAMA Neurol. 2020 Apr 10;:
pubmed: 32275288
Int J Infect Dis. 2020 Jun;95:332-339
pubmed: 32334118